Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

This morning, we announced 12-month top line data from OSPREY, our randomized controlled trial for moderate to severe obstructive sleep apnea ... narrowing the drug-resistant epilepsy treatment ...

While CPAP helps improve breathing and reduce ... apnea, but it also highlights the deeper effects that sleep disorders can have on the body—and how we might begin to undo that damage. The ...

Non-pharmacological interventions such as mindfulness and exercise may improve ... sleeping. Sleep problems in MS can include insomnia (difficulty falling or staying asleep), sleep apnea (pauses ...

Husain, M.D., a professor of neurology and the division chief of epilepsy, sleep and neurophysiology in ... talk to your doctor to see if an alternative drug — either in the same class or a different ...

After 3 months on cenobamate maintenance therapy, 49.3% of patients achieved at least a 50% reduction in seizure frequency. Patients with drug-resistant epilepsy (DRE) treated with cenobamate ...

A new study reveals that air pollution may contribute to the development ... to drive changes that could ultimately reduce the number of new epilepsy cases," said Tresah Antaya, postdoctoral ...

slightly elevating the head of the bed may help reduce the number of apnea episodes. This solution may be effective for people who have sleep apnea that worsens when they lie on their back but who ...